Innovation

Facile, High Yield Synthesis and Purification of CdS Quantum Dots from Optimized Strains of S. maltophilia

Lehigh University Office of Technology Transfer
posted on 08/27/2011

Quantum Dot Synthesis

Description:

A major barrier to the utilization of quantum dots (QDs) in commercial applications is the high cost associated with conventional chemical synthesis as well as the use of high temperatures and toxic solvents, thereby requiring specialized, expensive waste disposal procedures. Lehigh University has developed an optimized, bacterial-based synthesis method for semiconductor quantum dots that does not require expensive reagents, solvents or other materials. The process is capable of producing large quantities of QDs from a continuous process at a cost less than $1 per gram, whereas traditional technology an cost upwards of $10,000 per gram.1,2 The technology enables the producing of QDs on a scale necessary for their successful use in a number of commercial applications such in solar cells, light emitting diodes and medical imaging.  Lehigh Tech ID#081211-01.

 

The Market :

It is predicted that the market for products relying on quantum dots will reach $721 million in 2013, which is up from $28.6 million in 2008. This is a large growth prediction, mainly based on higher demands for energy efficient technologies where QDs can have a significant impact. Currently QDs has established themselves in a niche market for life sciences and biomedical applications, but improvements in manufacturing of QDs focused on cost reduction will open up opportunity within the energy sector, especially within solar cells products whose market is expected to reach $96 billion in the next three years. 3,4,5

 

The Opportunity:

Lehigh University is interested in both licensing this technology or in finding investment partners to establish a start-up for this technology.     

 

About Lehigh University:

Lehigh University is a leading research university with an enrollment of approximately 8,000 undergraduate and graduate students. 

 

For More Information on this Technology Contact:

Yatin S. Karpe, Ph.D.
Associate Director

Office of Technology Transfer
Lehigh University
354 Whitaker Laboratory
5 East Packer Ave.
Bethlehem, PA 18015

Phone: (610) 758-5841
Fax: (610) 758-5888 fax
Email: yatin.karpe@lehigh.edu
Web: http://www.lehigh.edu/ott

 

Claire Casola

Licensing Coordinator

Foresight Science & Technology

Phone & Email: 401-273-4844 ext. 17; claire.casola@foresightst.com

http://www.foresightst.com/index.html

 

 

[1] "Quantum Dots Go Large." June 10, 2009. Nature Magazine. Nature web site (subscription required). http://www.nature.com (accessed August 12, 2011).

[2] Patel, Prachi.. "Quantum Dots as Solar Cells." April 4, 2011. Technology Review web site. http://www.technologyreview.com/energy/37248/ (accessed August 12, 2011).

[3] "Quantum Dots: Technical Status and Market Prospective." BCC Research web site. http://www.bccresearch.com/report/NAN027B.html (accessed August 25, 2011).

[4] "Solar Energy Market Growth." 2010 Solar Buzz: Solar Market and Analysis web site. http://solarbuzz.com/facts-and-figures/markets-growth/market-growth (accessed August 12, 2011).

 

]]>


Innovation Details
 

File Number: 081211-01 


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Yatin Karpe at Lehigh University Office of Technology Transfer for more information.

Request more info via email request more info
People

Case Manager:

Yatin Karpe Yatin Karpe

Innovations (66)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

8,793 members 16,677 innovations 159 organizations

Browse

Scott Steele, coordinator of the CTSA-IP initiative and director of research alliances at the University of Rochester

"With more than 3,700 innovations from CTSA member institutions already on the iBridge Network, we're garnering worldwide exposure for the breakthroughs our researchers are accomplishing while moving toward our goal of increasing human health through clinical and translational research."  read more...